Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status
Само за регистроване кориснике
2019
Аутори
Milosavljević, FilipBukvić, Nikola
Pešić, Vesna
Pavlović, Zorana
Miljević, Čedo
Molden, Espen
Ingelman-Sundberg, Magnus
Jukić, Marin
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуКључне речи:
Antidepressant / Antipsychotic / Pharmacokinetics / Pharmacogenetics / Precision Medicine Neuropsychiatric DiseasesИзвор:
Neuropsychopharmacology, 2019, 44, 139-Издавач:
- Springer Nature
Напомена:
- ACNP 58th Annual Meeting: Poster Session
DOI: 10.1038/s41386-019-0545-y
ISSN: 0893-133X
PubMed: 31801976
WoS: 000509665600273
[ Google Scholar ]Институција/група
PharmacyTY - CONF AU - Milosavljević, Filip AU - Bukvić, Nikola AU - Pešić, Vesna AU - Pavlović, Zorana AU - Miljević, Čedo AU - Molden, Espen AU - Ingelman-Sundberg, Magnus AU - Jukić, Marin PY - 2019 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4752 PB - Springer Nature C3 - Neuropsychopharmacology T1 - Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status IS - 44 SP - 139 DO - 10.1038/s41386-019-0545-y ER -
@conference{ author = "Milosavljević, Filip and Bukvić, Nikola and Pešić, Vesna and Pavlović, Zorana and Miljević, Čedo and Molden, Espen and Ingelman-Sundberg, Magnus and Jukić, Marin", year = "2019", publisher = "Springer Nature", journal = "Neuropsychopharmacology", title = "Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status", number = "44", pages = "139", doi = "10.1038/s41386-019-0545-y" }
Milosavljević, F., Bukvić, N., Pešić, V., Pavlović, Z., Miljević, Č., Molden, E., Ingelman-Sundberg, M.,& Jukić, M.. (2019). Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status. in Neuropsychopharmacology Springer Nature.(44), 139. https://doi.org/10.1038/s41386-019-0545-y
Milosavljević F, Bukvić N, Pešić V, Pavlović Z, Miljević Č, Molden E, Ingelman-Sundberg M, Jukić M. Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status. in Neuropsychopharmacology. 2019;(44):139. doi:10.1038/s41386-019-0545-y .
Milosavljević, Filip, Bukvić, Nikola, Pešić, Vesna, Pavlović, Zorana, Miljević, Čedo, Molden, Espen, Ingelman-Sundberg, Magnus, Jukić, Marin, "Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status" in Neuropsychopharmacology, no. 44 (2019):139, https://doi.org/10.1038/s41386-019-0545-y . .